Efficacy of Aflibercept for macular edema in our hospital

Not Applicable

• Conditions: diabetic macular edema, retinal vein occlusion

• Registration Number: JPRN-UMIN000048108
• Lead Sponsor: Chiba University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-06-20
• Study Completion: 2023-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have not been followed up for more than 1 year

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Central retinal thickness and best corrected visual acuity one month after the 3rd to 12th vitreal injection of Aflibercept